USD
+$0.00
(+0.00%
)At Close (As of Dec 9, 2025)
$190.47M
Market Cap
-
P/E Ratio
-0.99
EPS
$3.38
52 Week High
$0.69
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $5.7M |
| Total Revenue | $5.7M |
| Cost Of Revenue | $3.8M |
| Costof Goods And Services Sold | $3.8M |
| Operating Income | -$81M |
| Selling General And Administrative | $19M |
| Research And Development | $67M |
| Operating Expenses | $86M |
| Investment Income Net | - |
| Net Interest Income | $5.2M |
| Interest Income | $5.2M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3.8M |
| Income Before Tax | -$75M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$75M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$81M |
| Ebitda | -$77M |
| Net Income | -$75M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $5.7M |
| Total Revenue | $5.7M |
| Cost Of Revenue | $3.8M |
| Costof Goods And Services Sold | $3.8M |
| Operating Income | -$81M |
| Selling General And Administrative | $19M |
| Research And Development | $67M |
| Operating Expenses | $86M |
| Investment Income Net | - |
| Net Interest Income | $5.2M |
| Interest Income | $5.2M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3.8M |
| Income Before Tax | -$75M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$75M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$81M |
| Ebitda | -$77M |
| Net Income | -$75M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Shattuck Labs, Inc. is a clinical-stage biotechnology firm headquartered in Austin, Texas, specializing in the development of innovative therapies for cancer and autoimmune diseases. Utilizing its proprietary technology platforms, the company focuses on creating targeted treatments that address critical unmet medical needs in the healthcare landscape. With a robust commitment to research and development, Shattuck Labs aims to significantly enhance patient outcomes by delivering next-generation therapeutics, positioning itself as a competitive player in the biopharmaceutical industry.